Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description

Delivery of Health Care Headache / therapy Headache Disorders Humans Primary Health Care
Barriers to care Global Campaign against headache Headache disorders Health policy Health-technology assessment Needs assessment Primary care Public health Service organization and delivery Structured headache services

Journal

The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562

Informations de publication

Date de publication:
21 07 2021
Historique:
received: 07 04 2021
accepted: 25 05 2021
entrez: 22 7 2021
pubmed: 23 7 2021
medline: 24 7 2021
Statut: epublish

Résumé

In countries where headache services exist at all, their focus is usually on specialist (tertiary) care. This is clinically and economically inappropriate: most headache disorders can effectively and more efficiently (and at lower cost) be treated in educationally supported primary care. At the same time, compartmentalizing divisions between primary, secondary and tertiary care in many health-care systems create multiple inefficiencies, confronting patients attempting to navigate these levels (the "patient journey") with perplexing obstacles.High demand for headache care, estimated here in a needs-assessment exercise, is the biggest of the challenges to reform. It is also the principal reason why reform is necessary.The structured headache services model presented here by experts from all world regions on behalf of the Global Campaign against Headache is the suggested health-care solution to headache. It develops and refines previous proposals, responding to the challenge of high demand by basing headache services in primary care, with two supporting arguments. First, only primary care can deliver headache services equitably to the large numbers of people needing it. Second, with educational supports, they can do so effectively to most of these people. The model calls for vertical integration between care levels (primary, secondary and tertiary), and protection of the more advanced levels for the minority of patients who need them. At the same time, it is amenable to horizontal integration with other care services. It is adaptable according to the broader national or regional health services in which headache services should be embedded.It is, according to evidence and argument presented, an efficient and cost-effective model, but these are claims to be tested in formal economic analyses.

Identifiants

DOI: 10.1186/s10194-021-01265-z PMID: 34289806 PMC: PMC8293530
pubmed: 34289806
doi: 10.1186/s10194-021-01265-z
pii: 10.1186/s10194-021-01265-z
pmc: PMC8293530
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78

Informations de copyright

© 2021. The Author(s).

Références

J Headache Pain. 2015;16:513
pubmed: 25924792
J Headache Pain. 2011 Oct;12(5):541-9
pubmed: 21660430
J Headache Pain. 2016 Dec;17(1):111
pubmed: 27933580
J Headache Pain. 2018 Nov 28;19(1):116
pubmed: 30486777
J Headache Pain. 2013 Jun 03;14:47
pubmed: 23731663
Can J Neurol Sci. 1993 May;20(2):131-7
pubmed: 8334575
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Ann Pharmacother. 2008 Jan;42(1):39-45
pubmed: 18073328
BMJ. 1995 Dec 2;311(7018):1447-8
pubmed: 8520313
Headache. 2012 Apr;52(4):582-91
pubmed: 22590713
JAMA Pediatr. 2016 Mar;170(3):267-87
pubmed: 26810619
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Acta Neurol Scand. 2015 Jul;132(1):16-22
pubmed: 25345990
J Headache Pain. 2013 Dec 24;14:101
pubmed: 24367919
J Headache Pain. 2005 Oct;6(5):373-7
pubmed: 16362709
J Headache Pain. 2016 Dec;17(1):74
pubmed: 27562856
J Headache Pain. 2014 Jan 08;15:3
pubmed: 24400999
J Headache Pain. 2015 Feb 18;16:15
pubmed: 25869942
Headache. 2001 Jul-Aug;41(7):638-45
pubmed: 11554951
Lancet Glob Health. 2015 Nov;3(11):e712-23
pubmed: 26475018
J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):436-8
pubmed: 2786922
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Headache. 2004 Jan;44(1):8-19
pubmed: 14979878
Headache. 1998 Nov-Dec;38(10):736
pubmed: 11279900
Cephalalgia. 2021 Jul;41(8):905-912
pubmed: 33601941
J Headache Pain. 2015;17:3
pubmed: 26810487
Neurol Sci. 2021 May;42(5):1869-1877
pubmed: 32948933
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Neurology. 2003 Feb 11;60(3):441-8
pubmed: 12578925
Expert Opin Pharmacother. 2021 Feb;22(3):305-316
pubmed: 33003955
BMJ. 1995 Oct 21;311(7012):1076-80
pubmed: 7580669
J Headache Pain. 2007 Jun;8(3):149-51
pubmed: 17563844
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Eur J Neurol. 2014 May;21(5):758-65
pubmed: 24520863
J R Coll Physicians Lond. 1996 Sep-Oct;30(5):426-31
pubmed: 8912281
J Headache Pain. 2019 Nov 5;20(1):100
pubmed: 31690261
Cephalalgia. 2007 Mar;27(3):193-210
pubmed: 17381554
Eur J Neurol. 2018 Mar;25(3):497-502
pubmed: 29171132
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
J Headache Pain. 2018 Feb 1;19(1):10
pubmed: 29392600
Prim Health Care Res Dev. 2019 Jan;20:e4
pubmed: 29848391
Arch Intern Med. 1999 Apr 26;159(8):813-8
pubmed: 10219926
J Headache Pain. 2011 Apr;12(2):201-17
pubmed: 21181425
J Headache Pain. 2014 May 21;15:31
pubmed: 24884549
Pain. 2011 Jun;152(6):1334-1339
pubmed: 21396772
J Headache Pain. 2019 May 21;20(1):57
pubmed: 31113373
J Headache Pain. 2018 Feb 27;19(1):18
pubmed: 29484508
Cephalalgia. 2021 Jun;41(7):810-820
pubmed: 33525903
J Headache Pain. 2012 Aug;13(6):449-57
pubmed: 22733141
J Headache Pain. 2014 Aug 15;15:51
pubmed: 25127664
Qual Health Care. 1999 Mar;8(1):16-21
pubmed: 10557664
N Engl J Med. 2001 Nov 1;345(18):1312-7
pubmed: 11794151
Cephalalgia. 1998 Jan;18(1):52-6
pubmed: 9601625
J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):104-105
pubmed: 31208991
J Headache Pain. 2015;16:537
pubmed: 26059349
Future Healthc J. 2018 Oct;5(3):151-155
pubmed: 31098557
Eur J Neurol. 2012 Aug;19(8):1093-9
pubmed: 22360745
J Headache Pain. 2019 Mar 4;20(1):24
pubmed: 30832585
Cephalalgia. 2001 Feb;21(1):25-30
pubmed: 11298660
J Headache Pain. 2015 Jan 20;15:7
pubmed: 25605131
Headache. 2009 Jan;49(1):79-89
pubmed: 19125877
Eur J Epidemiol. 2005;20(12):1007-14
pubmed: 16331432
J Headache Pain. 2018 Feb 21;19(1):17
pubmed: 29468450
Intern Emerg Med. 2008 Oct;3 Suppl 1:S25-8
pubmed: 18792808
Lancet. 2008 Sep 13;372(9642):1001-7
pubmed: 18790322
J Headache Pain. 2013 Oct 30;14:88
pubmed: 24171915
Cephalalgia. 2017 Mar;37(3):225-235
pubmed: 27053061
Cephalalgia. 2011 Jul;31(9):1039-47
pubmed: 21636624
Neurology. 2002 Mar 26;58(6):885-94
pubmed: 11914403
J Headache Pain. 2016;17:24
pubmed: 26969188
Cephalalgia. 2018 Apr;38(4):639-645
pubmed: 28376660
Cephalalgia. 2003 May;23(4):280-6
pubmed: 12716346
J Headache Pain. 2011 Aug;12(4):419-26
pubmed: 21380555
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(1. Vyp. 2):28-42
pubmed: 28514331
Headache. 2003 Jul-Aug;43(7):715-24
pubmed: 12890125
Eur J Neurol. 2012 May;19(5):703-11
pubmed: 22136117
Lancet Neurol. 2004 Apr;3(4):204-5
pubmed: 15039030
Cephalalgia. 2012 Oct;32(14):1019-20
pubmed: 23043131
Lancet Neurol. 2018 Nov;17(11):954-976
pubmed: 30353868
Headache. 2014 Apr;54(4):601-9
pubmed: 24666114
Cephalalgia. 2014 May;34(6):409-25
pubmed: 24293089
Cephalalgia. 2003 Feb;23(1):59-66
pubmed: 12534583
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
J Headache Pain. 2017 Dec;18(1):55
pubmed: 28477307

Auteurs

Timothy J Steiner (TJ)

Department of Neuromedicine and Movement Science, NTNU Norwegian University of Science and Technology, Edvard Griegs gate, Trondheim, Norway. t.steiner@imperial.ac.uk.
Division of Brain Sciences, Imperial College London, London, UK. t.steiner@imperial.ac.uk.

Rigmor Jensen (R)

Danish Headache Centre, Department of Neurology, University of Copenhagen, Rigshospitalet Glostrup, Glostrup, Denmark.

Zaza Katsarava (Z)

Evangelical Hospital Unna, Unna, Germany.
Department of Neurology, University of Duisburg-Essen, Essen, Germany.
EVEX Medical Corporation, Tbilisi, Georgia.
IM Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.

Lars Jacob Stovner (LJ)

Department of Neuromedicine and Movement Science, NTNU Norwegian University of Science and Technology, Edvard Griegs gate, Trondheim, Norway.
Norwegian Advisory Unit on Headache, Department of Neurology and Clinical Neurophysiology, St Olavs University Hospital, Trondheim, Norway.

Derya Uluduz (D)

Neurology Department, Cerrahpaşa School of Medicine, Istanbul University, Istanbul, Turkey.

Latifa Adarmouch (L)

Community Medicine and Public Health Department, Cadi Ayyad University School of Medicine, Marrakech, Morocco.

Mohammed Al Jumah (M)

Department of Neurosciences, King Fahad Medical City, MOH, Riyadh, Saudi Arabia.

Ali M Al Khathaami (AM)

King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Messoud Ashina (M)

Danish Headache Centre, Department of Neurology, University of Copenhagen, Rigshospitalet Glostrup, Glostrup, Denmark.

Mark Braschinsky (M)

Headache Clinic, Neurology Clinic, Tartu University Hospital, Tartu, Estonia.

Susan Broner (S)

Weill Cornell Medicine Headache Program, Department of Neurology, Weill Cornell Medical College, New York, NY, USA.

Jon H Eliasson (JH)

Department of Neurology, Centralsjukhuset, Kristianstad, Sweden.

Raquel Gil-Gouveia (R)

Headache Centre, Neurology Department, Hospital da Luz, Lisbon, Portugal.

Juan B Gómez-Galván (JB)

Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain.

Larus S Gudmundsson (LS)

Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Reykjavik, Iceland.

Akbar A Herekar (AA)

Department of Anesthesiology, Medical College of Georgia, Augusta University, Augusta, GA, USA.

Nfwama Kawatu (N)

Department of Paediatrics, University Teaching Hospital, Lusaka, Zambia.

Najib Kissani (N)

Laboratory of Clinical and Experimental Neuroscience, Faculty of Medicine, Université Cadi Ayyad Marrakech, Marrakech, Morocco.
Department of Neurology, University Teaching Hospital Mohammed VI, Marrakech, Morocco.

Girish Baburao Kulkarni (GB)

Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.

Elena R Lebedeva (ER)

Department of Neurology and Neurosurgery, The Ural State Medical University, Yekaterinburg, Russia.
International Headache Centre "Europe-Asia", Yekaterinburg, Russia.

Matilde Leonardi (M)

Neurology, Public Health, Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Mattias Linde (M)

Department of Neuromedicine and Movement Science, NTNU Norwegian University of Science and Technology, Edvard Griegs gate, Trondheim, Norway.
Norwegian Advisory Unit on Headache, Department of Neurology and Clinical Neurophysiology, St Olavs University Hospital, Trondheim, Norway.
Tjörn Headache Clinic, Rönnäng, Sweden.

Otgonbayar Luvsannorov (O)

Department of Neurology, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.

Youssoufa Maiga (Y)

Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Ivan Milanov (I)

Department of Neurology, University Hospital of Neurology and Psychiatry "St Naum", Medical University Sofia, Sofia, Bulgaria.

Dimos D Mitsikostas (DD)

1st Neurology Department, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Teymur Musayev (T)

Chief of Department of Health Organization, Ministry of Health, Baku, Azerbaijan.

Jes Olesen (J)

Danish Headache Centre, Department of Neurology, University of Copenhagen, Rigshospitalet Glostrup, Glostrup, Denmark.

Vera Osipova (V)

Moscow Research Clinical Centre for Neuropsychiatry, Moscow, Russian Federation.
University Headache Clinic, Moscow, Russian Federation.

Koen Paemeleire (K)

Department of Neurology, Ghent University Hospital, Ghent, Belgium.

Mario F P Peres (MFP)

Institute of Psychiatry, University of São Paulo, Hospital Albert Einstein, São Paulo, Brazil.

Guiovanna Quispe (G)

Department of Neurology, Hospital Luis Negreiros Vega, Callao, Lima, Peru.

Girish N Rao (GN)

Department of Epidemiology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.

Ajay Risal (A)

Department of Psychiatry, Kathmandu University School of Medical Sciences (KUSMS), Dhulikhel, Kavre, Nepal.
Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Kavre, Nepal.

Elena Ruiz de la Torre (ER)

European Migraine and Headache Alliance, Valencia, Spain.

Deanna Saylor (D)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia.

Mansoureh Togha (M)

Neurology Ward, Sina Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Headache Department, Iranian Center of Neurological Researches, Institute of Neuroscience, Tehran University of Medical Sciences, Tehran, Iran.

Sheng-Yuan Yu (SY)

International Headache Centre, Department of Neurology, Chinese PLA General Hospital, Beijing, China.

Mehila Zebenigus (M)

Department of Neurology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Yared Zenebe Zewde (YZ)

Department of Neurology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Jasna Zidverc-Trajković (J)

Neurology Clinic, Clinical Centre of Serbia, Belgrade, Serbia.

Michela Tinelli (M)

Care Policy and Evaluation Centre, The London School of Economics and Political Science, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

Recherchemedicale.com › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Structured headache services as the solution...
Recherchemedicale.com › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Céphalée › Structured headache services as the solution...
Recherchemedicale.com › Maladies du système nerveux › Maladies du système nerveux central › Encéphalopathies › Céphalées › Structured headache services as the solution...
Recherchemedicale.com › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Structured headache services as the solution...
Recherchemedicale.com › Administration des services de santé › Gestion des soins aux patients › Services de santé polyvalents › Soins de santé primaires › Structured headache services as the solution...